Cited by 176RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryBarrier Structure and Function Studies

The DOI matches its Crossref record; 55 of the 59 references it cites were found in a registry or an index.

shRNA and siRNA delivery to the brain

Open access

Pardridge, William M.·2007·Advanced Drug Delivery Reviews

DOI 10.1016/j.addr.2007.03.008PMC PMC3572210

Open this paper in CoChat — free account

Abstract

The limiting factor in in vivo RNA interference (RNAi) is delivery. Drug delivery methods that are effective in cell culture may not be practical in vivo for intravenous RNAi applications. Nucleic acid drugs are highly charged and do not cross cell membranes by free diffusion. Therefore, the in vivo delivery of RNAi therapeutics must use targeting technology that enables the RNAi therapeutic to traverse biological membrane barriers in vivo. For RNAi of the brain, the nucleic acid-based drug must first cross the brain capillary endothelial wall, which forms the blood-brain barrier (BBB) in vivo, and then traverses the brain cell plasma membrane. Similar to the delivery of non-viral gene therapies, plasmid DNA encoding for short hairpin RNA (shRNA) may be delivered to the brain following intravenous administration with pegylated immunoliposomes (PILs). The plasmid DNA is encapsulated in a 100 nm liposome, which is pegylated, and conjugated with receptor specific targeting monoclonal antibodies (MAb). Weekly, intravenous RNAi with PILs enables a 90% knockdown of the human epidermal growth factor receptor, which results in a 90% increase in survival time in mice with intra-cranial brain cancer. Similar to the delivery of antisense agents, short interfering RNAi (siRNA) duplexes can be delivered with the combined use of targeting MAb's and avidin-biotin technology. The siRNA is mono-biotinylated in parallel with the production of a conjugate of the targeting MAb and streptavidin. Intravenous RNAi requires the combined use of RNAi technology and a drug targeting technology that is effective in vivo.

Integrity signals

Registry

Crossref · 10.1016/j.addr.2007.03.008

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
EGFR and cancer prognosis.
Nicholson, R., Gee, J., & Harper, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,132
Avidin
Green, N. M. (1975) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60411-8 · Cited by 1,472
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,400
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C., & Cheng, Y. C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,300
RNAi in Human Cells
Chiu, Y., & Rana, T. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00652-4 · Cited by 400
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer
Zhang, Y., Zhang, Y., Bryant, J., Charles, A. C., Boado, R. J., & Pardridge, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0740 · Cited by 330
EGF mutant receptor vIII as a molecular target in cancer therapy.
Kuan, C., Wikstrand, C. J., & Bigner, D. D. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080083 · Cited by 325
Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate
Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 324

Flagged first, then by citations

Show all 59 references

4 of the 59 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–176 of 176

A Comparison of RNA Interference via Injection and Feeding in Honey Bees
Zhang, Y., Li, Z., Wang, Z.-L., Zhang, L., & Zeng, Z. J. (2022) · Insects · doi:10.3390/insects13100928 · Cited by 14
Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells
Ashizawa, A. T., Holt, J., Faust, K., Liu, W., Tiwari, A., Zhang, N., & Ashizawa, T. (2018) · The Cerebellum · doi:10.1007/s12311-018-0961-2 · Cited by 15
Nanodelivery of therapeutic agents in Parkinson's disease
Lafuente, J. V., Requejo, C., & Ugedo, L. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.004 · Cited by 14
Substance P Derivatives as Versatile Tools for Specific Delivery of Various Types of Biomolecular Cargo
Rizk, S. S., Misiura, A., Paduch, M., & Kossiakoff, A. A. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200496e · Cited by 12
Glioma Growth Inhibition In Vitro and In Vivo by Single Chain Variable Fragments of the Transferrin Receptor Conjugated to Survivin Small Interfering RNA
Wang, F., Bai, H.-R., Wang, J., Bai, Y.-Z., & Dou, C. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900512 · Cited by 12
Nanostructures Overcoming the Blood-Brain Barrier: Physiological Considerations and Mechanistic Issues
Lalatsa, A., Schätzlein, A. G., & Uchegbu, I. F. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00329 · Cited by 12
Neutral Liposomes and DNA Transfection
Pisani, M., Mobbili, G., & Bruni, P. (2011) · InTech eBooks · doi:10.5772/21283 · Cited by 11
Spatially Precise Genetic Engineering at the Electrode‐Tissue Interface
Xu, K., Yang, Y., Ding, J., Wang, J., Fang, Y. Z., & Tian, H. (2024) · Advanced Materials · doi:10.1002/adma.202401327 · Cited by 9
Tiny non-coding RNAs in Parkinson’s disease: Implications, expectations and hypes
Srivastava, G., Dixit, A., Prakash, O., & Singh, M. P. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.07.009 · Cited by 9
Mono- and Polyassociation Processes of Pentavalent Biotinylated PEI Glycopolymers for the Fabrication of Biohybrid Structures with Targeting Properties
Fingernagel, J., Boye, S., Kietz, A., Höbel, S., Wozniak, K., Moreno, S., Janke, A., Lederer, A., Aigner, A. M., Temme, A., et al. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00667 · Cited by 9
Drug Delivery Across the Blood–Brain Barrier
Lalatsa, A., Schätzlein, A. G., & Uchegbu, I. F. (2011) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00313-x · Cited by 9
Biotin-phenosafranin as a new photosensitive conjugate for targeted therapy and imaging
Błauż, A., Rychlik, B., Plażuk, D., Peccati, F., Jiménez‐Osés, G., Steinke, U., Sierant, M., Trzeciak, K., Skorupska, E. A., & Miksa, B. (2021) · New Journal of Chemistry · doi:10.1039/d0nj06170k · Cited by 9
Potential application of RNAi for understanding and therapy of neurodegenerative diseases
Elena, I. S. (2009) · Frontiers in bioscience · doi:10.2741/3245 · Cited by 9
Innovative nonviral vectors for small-interfering RNA delivery and therapy
Arruda, D. C., Hoffmann, C., Charrueau, C., Bigey, P., & Escriou, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46142-9.00026-8 · Cited by 8
RNA Interference Therapeutics for Tumor Therapy
Tsujiuchi, T., Miller, A. D., Wakabayashi, T., & Natsume, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00027-5 · Cited by 8
Optimization and apoptosis induction by RNAi with UTMD technology in vitro
Chen, Z., Liang, K., Sheng, X., Situ, B., Sun, X., Liu, J., Qiu, R.-X., ZHANG, H., Li, Y., ZHOU, X.-X., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.610 · Cited by 8
This is the pre-peer-reviewed version of the following article:
Sm, C., Berger, S., Cannon, R. C., Ap, D., Djurfeldt, M., Eppler, J. M., Kriener, B., Furber, S. B., Graham, B. P., He, P., et al. (2012) · Cited by 8
Tissue-Specific Delivery of Oligonucleotides
Xia, X., Pollock, N., Zhou, J., & Rossi, J. J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9670-4_2 · Cited by 7
Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells
Yang, J., Wang, R., Li, H., Lv, Q., Meng, W., & Yang, X. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160636 · Cited by 7
Advances in Neurotherapeutic Delivery Technologies
Mr Pradeep, K. (2015) · OMICS International eBooks · doi:10.4172/978-1-63278-036-2-037 · Cited by 6
Entry granted
Cantin, E. M., & Rossi, J. J. (2007) · Nature · doi:10.1038/448033a · Cited by 6
The bs-YHEDA peptide protects the brains of senile mice and thus recovers intelligence by reducing iron and free radicals
Gao, X., Wang, Z., Xiong, L., Wu, F., Gan, X., Liu, J., Huang, X., Liu, J., Tang, L., Li, Y., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.014 · Cited by 6
Associative memory cells of encoding fear signals and anxiety are recruited by neuroligin-3-mediated synapse formation
Chen, B., Zhang, Y., Xiao, H., Wang, L., Li, J., Xu, Y., & Wang, J. (2024) · Communications Biology · doi:10.1038/s42003-024-07170-w · Cited by 4
Strategies and Approaches for siRNA Delivery
SONI, D. M. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i3-s.4086 · Cited by 4
Containers Based Drug Delivery for Neuroscience
Jose, D. A., Krishnapriya, & Chakrapani, P. S. B. (2022) · Composites science and technology · doi:10.1007/978-981-16-8146-2_14 · Cited by 4
Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3-mediated new synapse formation
Xu, Y., Cui, T.-L., Li, J.-Y., Chen, B., & Wang, J.-H. (2023) · eLife · doi:10.7554/elife.87969 · Cited by 4
Optical accelerator of nanoparticles
Shalin, A. S. (2011) · Journal of Communications Technology and Electronics · doi:10.1134/s1064226911080109 · Cited by 4
Gene Silencing in the Brain with siRNA to Promote Long-Term Post-Stroke Recovery
Chelluboina, B., & Vemuganti, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2926-0_29 · Cited by 3
Targeting Chemotherapy Resistance in Glioblastoma Through Modulation of ABC Transporters
Tivnan, A. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46505-0_2 · Cited by 3
Emerging Role of microRNAs in Cerebral Stroke Pathophysiology
Tripathi, A. K., Tiwari, S. K., Mishra, P., & Jain, M. K. (2019) · Springer eBooks · doi:10.1007/978-981-13-1453-7_10 · Cited by 3
Functionalized biopolymer-based drug delivery systems: current status and future perspectives
Layek, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821437-4.00020-7 · Cited by 3
Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3-mediated new synapse formation
Xu, Y., Cui, T.-L., Li, J.-Y., Chen, B., & Wang, J.-H. (2023) · eLife · doi:10.7554/elife.87969.3 · Cited by 3
Auditory cortical neurons are recruited to encode fear signals and anxiety by neuroligin-3-mediated synapse formation
Zhang, Y., Chen, B., Li, J., Wang, L., Xu, Y., & Wang, J. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03357-9 · Cited by 3
The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics
Tian, M., & Gabathuler, R. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_5 · Cited by 3
Chapter 8 Manipulation of PKC Isozymes by RNA Interference and Inducible Expression of PKC Constructs
Basu, A., Persaud, S. D., & Sivaprasad, U. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01608-x · Cited by 3
Développement de nouveaux vecteurs protéiniques pour le transport physiologique d’agents thérapeutiques vers le système nerveux central
Gabathuler, R. (2012) · Biologie Aujourd hui · doi:10.1051/jbio/2012018 · Cited by 4
Using RNA Interference to Downregulate G Protein-Coupled Receptors
Sarret, P., Doré-Savard, L., Tétreault, P., Bégin-Lavallée, V., Dansereau, M., & Beaudet, N. (2011) · Neuromethods · doi:10.1007/978-1-61779-179-6_19 · Cited by 3
Nanomedicines for Delivery Across the Blood–Brain Barrier
Lalatsa, A., Das, D., & Osouli-Bostanabad, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_11 · Cited by 2
Neuroligin-3-Mediated Synapse Formation Strengthens Interactions between Hippocampus and Barrel Cortex in Associative Memory
Xiao, H., Xu, Y., Cui, S., & Wang, J.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020711 · Cited by 2
Polypeptides and Engineered Proteins
Liu, X., Hu, J., Wang, Z., Xu, Z., & Gao, W. (2017) · ACS symposium series · doi:10.1021/bk-2017-1252.ch006 · Cited by 2
RNAi-based Approaches to the Treatment of Brain Tumors
Mathupala, S. P., Mittal, S., Guthikonda, M., & Sloan, A. E. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_22 · Cited by 2
Targeted delivery of siRNA to differentiated murine myotubes in culture by a conjugate of cationic oligopeptide with FS2 venom
Furalyov, V. A., Кравченко, И. В., & Popov, V. O. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913040111 · Cited by 2
MicroRNA Biomarkers for Stroke
Zhang, X., Sun, P., & Yin, K. (2017) · Translational medicine research · doi:10.1007/978-981-10-5804-2_15 · Cited by 2
Pharmacokinetics of Systemic Drug Delivery
O’Connor, C., Ramanath, N., & Campbell, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00003-7 · Cited by 3
siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Parkinson’s disease
Singh, P., Mishra, N., Singh, N., Alka, Nisha, R., Maurya, P., Pal, R. R., & Saraf, S. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00002-2 · Cited by 2
Antibody–Drug Conjugates
Liu, X., & Gao, W. (2016) · Wiley eBooks · doi:10.1002/9783527694396.ch6 · Cited by 2
Associative memory neurons are recruited in PFC-centered circuits to encode schizophrenia-like behavior by dopaminergic receptor-II
Wang, L., Zhang, J., Geng, L., Chen, B., Li, J., Xu, Y., & Wang, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03388-0 · Cited by 1
ADDICTION: NEW ERA OF THERAPY
Hamid, O. I. A. (2014) · Egyptian Society of Clinical Toxicology Journal · doi:10.21608/esctj.2014.62850 · Cited by 1
IMPLICATIONS FOR THERAPY Personalized Therapy of Cancer
Yamanaka, K., & Lloyd, R. (2013) · CRC Press eBooks · doi:10.1201/b14587-12 · Cited by 1
Active Targeting of Nanomedicines
Serrano, D. R., Kara, A., Ramirez, B. I., Ramirez, I. O., Öngoren, B., & Lalatsa, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_14 · Cited by 1
Development of New Protein Vectors for the Physiologic Delivery of Large Therapeutic Compounds to the CNS
Gabathuler, R. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_16 · Cited by 1
Smart Microcapsules with Thermo-Responsive Hydrogel Membranes
Chu, L. (2011) · Advanced topics in science and technology in China · doi:10.1007/978-3-642-18114-6_4 · Cited by 1
Delivery Strategies for RNAi to the Nervous System
Foust, K. D., & Kaspar, B. K. (2011) · Neuromethods · doi:10.1007/978-1-61779-114-7_4 · Cited by 1
Liposomes as carriers: not as innocent as one would like
Gebhardt, R., & Matz‐Soja, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1574-x
Engineering Cell Function by RNA Interference
Gredell, J. A., Kini, H. K., & Walton, S. P. (2009) · Cell engineering · doi:10.1007/978-90-481-2245-5_9
Strategies for Microsphere‐Mediated Cellular Delivery
Sanchez-Martin, R. M., Alexander, L. M., Cárdenas‐Maestre, J. M., & Bradley, M. (2010) · doi:10.1002/9783527630516.ch5
Telomerase : a prognostic marker and therapeutic target
Thakkar, D. (2010) · CLOK (University of Central Lancashire)
A Role for the Fibroblast Growth Factor Family in Depression and Circadian Rhythms.
Inui, E. G. (2010) · Deep Blue (University of Michigan)
RNA Interference-Based Therapies Against Brain Tumors: Potential Clinical Strategies
Mathupala, S. P., Mittal, S., Guthikonda, M., & Sloan, A. E. (2009) · Springer eBooks · doi:10.1007/978-3-642-00475-9_14
Novel biosensors for preclinical brain tumor analysis
Niers, J. M. (2011) · Pure Amsterdam UMC
Analise de expressão do gene Lgi1 durante o desenvolvimento do sistema nervoso central e seu silenciamento utilizando a tecnica de interferencia por RNA
Araújo, P. A. O. R. D. A. (2008) · doi:10.47749/t/unicamp.2008.432456
Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.
Qureshi, I., & Mehler, M. F. (2011) · PubMed
Theranostic nanomaterials applied to the cancer diagnostic and therapy and nanotoxicity studies
Marangoni, V. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2016.tde-21102016-155818
Blood–Brain Barrier: Genomics, Proteomics, Disease Targets, and Drug Delivery
Duzenli, O. F., & Öner, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00002-2
Sex Differences, Progesterone, and Ischemic Stroke
Schumacher, M., & Guennoun, R. (2019) · ISGE series · doi:10.1007/978-3-030-11355-1_14
Molecular targeting of translesion synthesis DNA polymerases for novel combination chemotherapy
Yamanaka, K. (2015) · doi:10.6083/m47p8wd2
Active Targeting
Serrano, D. R., & Lalatsa, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9164-4_13
Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3 mediated new synapse formationPreprint
Xu, Y., Cui, T.-L., Li, J.-Y., Chen, B., & Wang, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.543188
Reviewer #1 (Public Review): Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3 mediated new synapse formation
(2023) · doi:10.7554/elife.87969.1.sa1
Reviewer #2 (Public Review): Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3 mediated new synapse formation
(2023) · doi:10.7554/elife.87969.1.sa0
eLife Assessment: Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3 mediated new synapse formation
Huguenard, J. R. (2023) · doi:10.7554/elife.87969.1.sa2
Associative memory neurons of encoding multi-modal signals are recruited by neuroligin-3 mediated new synapse formationPreprint
Xu, Y., Cui, T.-L., Li, J.-Y., Chen, B., & Wang, J. (2023) · eLife · doi:10.7554/elife.87969.2
Nanocarriers in Imaging
Shaikh, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7292-6_4
Cellular-nanoporation boosts high-yield RVG-modified exosomes for multifunctional α-synuclein scavengers against Parkinson's disease
Sun, M., Yu, L., Bai, L., Liu, X., Xiong, Y., Zhao, X., Zhong, X., Ran, M., Wang, Y., Yan, X., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111948
RNAi in Malignant Brain Tumors: Relevance to Molecular and Translational Research
Nakada, M., Kita, D., Hayashi, Y., Kawakami, K., Hamada, J., & Minamoto, T. (2010) · RNA technologies · doi:10.1007/978-3-642-12168-5_5
An RNA interference strategy for the treatment of Alzheimer's disease
Liu, X. (2021) · theses.fr (ABES) · doi:10.70675/35211b03z3b19z478czb3e2z8d35ab2170d6

Authors: Pardridge, W. M.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Pardridge, William M.
ORCID: Pardridge, William M.
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2007-03
Volume: 59
Issue: 2-3
Pages: 141-152
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/j.addr.2007.03.008
PMC: PMC3572210
OpenAlex: W2031687291
Cited by: 176
References: 59
Citations by year: 2025: 4 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 8 · 2020: 6 · 2019: 10 · 2018: 4 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 3 · 2013: 18 · 2012: 12
FWCI: 1.23
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS053540)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords: RNA interference, shRNA delivery, siRNA delivery, brain, blood-brain barrier, monoclonal antibody targeting, intravenous administration, epidermal growth factor receptor, brain cancer, nucleic acid drug delivery, membrane crossing
MeSH terms: Animals, Brain, Carrier Proteins, Humans, Plasmids, Reproducibility of Results, Drug Delivery Systems, RNA, Small Interfering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

shRNA and siRNA delivery to the brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks